1-16 of 16
Lin Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PS12-08: Biological sex-linked immune modulation but not cross-sex estrogen therapy reduces the efficacy of PARP inhibition in the treatment of Brca1 breast tumors

Free
Jan Heng, Lin Wang, Abhishek Thavamani, Erica S. Massicott, Brian R. Sardella, Vanessa C. Bret-Mounet, Zhaoji Liu, Steven R. Vandal, Emily K. Aronson, Gabrielle M. Baker, John G. Clohessy, Gerburg M. Wulf
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): PS12-08.
https://doi.org/10.1158/1557-3265.SABCS24-PS12-08
Published: 13 June 2025
View articletitled, Abstract PS12-08: Biological sex-linked immune modulation but not cross-sex estrogen therapy reduces the efficacy of PARP inhibition in the treatment of Brca1 breast tumors
Journal Articles

Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma

Open Access
Parvathi Sudha, Aarif Ahsan, Cody Ashby, Tasneem Kausar, Akhil Khera, Mohammad H. Kazeroun, Chih-Chao Hsu, Lin Wang, Evelyn Fitzsimons, Outi Salminen, Patrick Blaney, Magdalena Czader, Jonathan Williams, Mohammad I. Abu Zaid, Naser Ansari-Pour, Kwee L. Yong, Frits van Rhee, William E. Pierceall, Gareth J. Morgan, Erin Flynt, Sarah Gooding, Rafat Abonour, Karthik Ramasamy, Anjan Thakurta, Brian A. Walker
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2854–2864.
https://doi.org/10.1158/1078-0432.CCR-21-3695
Published: 01 July 2022
View articletitled, Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma
Open the PDF for Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer

Open Access
Wei-Xiong Xia, Xing Lv, Hu Liang, Guo-Ying Liu, Rui Sun, Qi Zeng, Si-Wei Li, Hao-Yuan Mo, Fei Han, Dong-Hua Luo, Qing Liu, Meng-Yun Shi, Yan-Fang Ye, Jing Yang, Liang-Ru Ke, Meng-Yun Qiang, Wen-Ze Qiu, Ya-Hui Yu, Kui-Yuan Liu, Xin-Jun Huang, Wang-Zhong Li, Shu-Hui Lv, Zhuo-Chen Cai, Jing-Jing Miao, Ling Guo, Ming-Yuan Chen, Ka-Jia Cao, Lin Wang, Chong Zhao, Pei-Yu Huang, Qiu-Yan Chen, Yi-Jun Hua, Lin-Quan Tang, Chao-Nan Qian, Hai-Qiang Mai, Xiang Guo, Yan-Qun Xiang
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4186–4194.
https://doi.org/10.1158/1078-0432.CCR-20-4532
Published: 01 August 2021
View articletitled, A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
Open the PDF for A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer in another window
Includes: Supplementary data
Journal Articles

Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Free
Xinan Sheng, Xieqiao Yan, Lin Wang, Yanxia Shi, Xin Yao, Hong Luo, Benkang Shi, Jiyan Liu, Zhisong He, Guohua Yu, Jianming Ying, Weiqing Han, Changlu Hu, Yun Ling, Zhihong Chi, Chuanliang Cui, Lu Si, Jianmin Fang, Aiping Zhou, Jun Guo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (1): 43–51.
https://doi.org/10.1158/1078-0432.CCR-20-2488
Published: 04 January 2021
View articletitled, Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Open the PDF for Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract GMM-021: UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY

Free
Magdalena Cybula, Katherine Moxley, Lin Wang, Luyao Wang, Magdalena Bieniasz
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): GMM-021.
https://doi.org/10.1158/1557-3265.OVCASYMP18-GMM-021
Published: 15 November 2019
View articletitled, Abstract GMM-021: UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
Journal Articles

Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Free
Zhenyu Liu, Xiao-Yan Zhang, Yan-Jie Shi, Lin Wang, Hai-Tao Zhu, Zhenchao Tang, Shuo Wang, Xiao-Ting Li, Jie Tian, Ying-Shi Sun
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23): 7253–7262.
https://doi.org/10.1158/1078-0432.CCR-17-1038
Published: 30 November 2017
View articletitled, Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Open the PDF for Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer in another window
Includes: Supplementary data
Journal Articles

Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies

Free
Netanya I. Pollock, Lin Wang, Gerald Wallweber, William E. Gooding, Weidong Huang, Ahmed Chenna, John Winslow, Malabika Sen, Kara A. DeGrave, Hua Li, Yan Zeng, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (20): 4597–4606.
https://doi.org/10.1158/1078-0432.CCR-14-3338
Published: 14 October 2015
View articletitled, Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies
Open the PDF for Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

Free
Ann Marie Egloff, Ju-Whei Lee, Corey J. Langer, Harry Quon, Alec Vaezi, Jennifer R. Grandis, Raja R. Seethala, Lin Wang, Dong M. Shin, Athanassios Argiris, Donghua Yang, Ranee Mehra, John Andrew Ridge, Urjeet A. Patel, Barbara A. Burtness, Arlene A. Forastiere
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5041–5051.
https://doi.org/10.1158/1078-0432.CCR-14-0051
Published: 30 September 2014
View articletitled, Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
Open the PDF for Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303 in another window
Includes: Supplementary data
Journal Articles

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Free
Neil D. Gross, Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang, Simion Chiosea, Brian L. Hood, Melanie S. Flint, Mai Sun, Thomas P. Conrads, Robert L. Ferris, Jonas T. Johnson, Seungwon Kim, Athanassios Argiris, Lori Wirth, Marina N. Nikiforova, Jill M. Siegfried, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (12): 3289–3298.
https://doi.org/10.1158/1078-0432.CCR-13-3360
Published: 12 June 2014
View articletitled, Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer
Open the PDF for Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells

Free
Michael S. Leibowitz, Raghvendra M. Srivastava, Pedro A. Andrade Filho, Ann Marie Egloff, Lin Wang, Raja R. Seethala, Soldano Ferrone, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (4): 798–808.
https://doi.org/10.1158/1078-0432.CCR-12-1517
Published: 14 February 2013
View articletitled, SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells
Open the PDF for SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer

Free
Malabika Sen, Sonali Joyce, Mary Panahandeh, Changyou Li, Sufi M. Thomas, Jessica Maxwell, Lin Wang, William E. Gooding, Daniel E. Johnson, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 4986–4996.
https://doi.org/10.1158/1078-0432.CCR-12-0792
Published: 16 September 2012
View articletitled, Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
Open the PDF for Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer in another window
Includes: Supplementary data
Journal Articles

Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma

Free
Sarah Wheeler, Doris R. Siwak, Raymond Chai, Courtney LaValle, Raja R. Seethala, Lin Wang, Kathleen Cieply, Carol Sherer, Corwin Joy, Gordon B. Mills, Athanassios Argiris, Jill M. Siegfried, Jennifer R. Grandis, Ann Marie Egloff
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (8): 2278–2289.
https://doi.org/10.1158/1078-0432.CCR-11-1593
Published: 16 April 2012
View articletitled, Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma
Open the PDF for Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

Free
Alec Vaezi, XiaoZhe Wang, Shama Buch, William Gooding, Lin Wang, Raja R. Seethala, David T. Weaver, Alan D. D'Andrea, Athanassios Argiris, Marjorie Romkes, Laura J. Niedernhofer, Jennifer R. Grandis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5513–5522.
https://doi.org/10.1158/1078-0432.CCR-11-0086
Published: 14 August 2011
View articletitled, XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck
Open the PDF for XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck in another window
Includes: Supplementary data
Journal Articles

Expression of the Tumor Suppressor Gene ARHI in Epithelial Ovarian Cancer Is Associated with Increased Expression of p21WAF1/CIP1 and Prolonged Progression-Free Survival

Free
Daniel G. Rosen, Lin Wang, Ajay N. Jain, Karen H. Lu, Robert Z. Luo, Yinhua Yu, Jinsong Liu, Robert C. Bast, Jr.
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (19): 6559–6566.
https://doi.org/10.1158/1078-0432.CCR-04-0698
Published: 08 October 2004
View articletitled, Expression of the Tumor Suppressor Gene ARHI in Epithelial Ovarian Cancer Is Associated with Increased Expression of p21WAF1/CIP1 and Prolonged Progression-Free Survival
Open the PDF for Expression of the Tumor Suppressor Gene ARHI in Epithelial Ovarian Cancer Is Associated with Increased Expression of p21WAF1/CIP1 and Prolonged Progression-Free Survival in another window
Journal Articles

Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis

Free
Karen H. Lu, Andrea P. Patterson, Lin Wang, Rebecca T. Marquez, Edward N. Atkinson, Keith A. Baggerly, Lance R. Ramoth, Daniel G. Rosen, Jinsong Liu, Ingegerd Hellstrom, David Smith, Lynn Hartmann, David Fishman, Andrew Berchuck, Rosemarie Schmandt, Regina Whitaker, David M. Gershenson, Gordon B. Mills, Robert C. Bast, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3291–3300.
https://doi.org/10.1158/1078-0432.CCR-03-0409
Published: 24 May 2004
View articletitled, Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
Open the PDF for Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis in another window
Journal Articles

Loss of the Expression of the Tumor Suppressor Gene ARHI Is Associated with Progression of Breast Cancer

Free
Lin Wang, Ashraful Hoque, Robert Z. Luo, Jiuhong Yuan, Zhen Lu, Arata Nishimoto, Jinsong Liu, Aysegul A. Sahin, Scott M. Lippman, Robert C. Bast, Jr., Yinhua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3660–3666.
Published: 23 September 2003
View articletitled, Loss of the Expression of the Tumor Suppressor Gene ARHI Is Associated with Progression of Breast Cancer
Open the PDF for Loss of the Expression of the Tumor Suppressor Gene ARHI Is Associated with Progression of Breast Cancer in another window